Avid Bioservices Inc (CDMO): Forward Price-to-Revenue Multiple

Public company logo of Avid Bioservices Inc (CDMO)

Avid Bioservices, Inc. (CDMO) focuses on the long-term expansion of production capacities to increase margins within the B2B sector. Synergy with biotech laboratories through strategic alliances accelerates the launch of new drugs. Logistics optimization and IT outsourcing allow the company to concentrate on the production of biologics. The forward P/S ratio helps identify asset overheating, with the value currently maintained at 5.30.

avidbio.com - CDMO Market Cap to Expected Sales Ratio (period 07/04/2022 - 02/16/2025)

Comprehensive metric breakdowns and analytics for Avid Bioservices, Inc. (CDMO)

- current price and projected stock value:
Stock Price Avid Bioservices Inc.|CDMO - Analyst Consensus Forecast
- stock exchange capitalization data:
Market Valuation Avid Bioservices, Inc.|CDMO - Total Company Value
- business book valuation details:
Book Value per Share Avid Bioservices|CDMO - Book Valuation of Business|Market Capitalization to Book Value Ratio avidbio.com|CDMO - Total Business Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Avid Bioservices, Inc.|CDMO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Avid Bioservices|CDMO - Company Debts|Debts to Book Capitalization Avid Bioservices, Inc|CDMO - Long-Term Debt Volume|Company Short-Term Debt Avid Bioservices|Quick Liquidity avidbio.com
- financial results and valuation multiples details:
CDMO - Net Financial Result|Projected Future Earnings Avid Bioservices, Inc.|CDMO - Market Cap to Earnings|Future Price to Earnings Avid Bioservices, Inc.|CDMO - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Avid Bioservices, Inc.|CDMO - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Avid Bioservices|CDMO - Net earnings per share for the last four quarters|Quarterly EPS earnings growth avidbio.com|CDMO - Net earnings per share growth this year|Earnings growth forecast for next year Avid Bioservices, Inc.
- sales volume and revenue indicators:
CDMO - Company Total Revenue|Company Projected Revenue Avid Bioservices Inc|CDMO - Price-to-Revenue Coefficient|Forward Price-to-Revenue Multiple Avid Bioservices Inc.|CDMO - Revenue Dynamics YoY (Last Twelve Months)
Summary company analytics:Avid Bioservices Inc CDMO
Manufactured products of Avid Bioservices Inc

This metric measures the market value of an asset relative to expected sales volume, allowing for an assessment of demand stability for shares regardless of trading volumes. By analyzing the forward P/S indicator, an investor determines the valuation volatility of Avid Bioservices, Inc. (CDMO), where a stable ratio confirms the value of capital barriers in the form of FDA-certified bioreactors and a high regulatory barrier to entry.

Analysis of competing companies

Price-to-Projected Revenue Ratio IQVIA Holdings IQV|Laboratory Corporation of America - Price-to-Projected Revenue Ratio|Medpace Holdings - Forward P/S Multiple|ICON (ICLR) - Forward Price-to-Revenue Multiple|Charles River (CRL) - Price-to-Projected Revenue Ratio|EVO: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple FTRE|Market Cap to Future Revenue Ratio Lifecore Biomedical LFCR|Forward P/S Multiple OABI|Market Cap to Expected Sales Ratio Inotiv|Forward P/S Multiple CTLT (Catalent, Inc)|Market Cap to Expected Sales Ratio NightHawk Biosciences (SCPX)